Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Mersana Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MRSN | Benzinga

Q: What sector and industry does Mersana Therapeutics (MRSN) operate in?

Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Mersana Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MRSN.

Open	$0.33
Close	$0.38
Volume / Avg.	1.83M / 4.15M
Day Range	$0.33 - $0.38
52 Wk Range	0.26 - 3.63
Market Cap	$41.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	10.28%
Days to Cover	2.86

Recent News

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?

Mersana shares Phase 1 data on Emi-Le for TNBC and details FDA's Fast Track status for XMT-1660 in advanced HER2-low breast cancer.

Vandana Singh

Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.33
Close	$0.38
Volume / Avg.	1.83M / 4.15M
Day Range	$0.33 - $0.38
52 Wk Range	0.26 - 3.63
Market Cap	$41.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	10.28%
Days to Cover	2.86

About Mersana Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibod...

Got Questions? Ask

How is MRSN's EV/EBITDA ratio?

What do MRSN's technical indicators suggest?

What is MRSN's all-time low price?

What is MRSN's dividend yield?

What is MRSN's P/S ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mersana Therapeutics (MRSN) stock?

You can purchase shares of Mersana Therapeutics (NASDAQ:MRSN) through any online brokerage.

View our list of the best stock brokerages

Who are Mersana Therapeutics (MRSN) competitors?

Other companies in Mersana Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), bluebird bio (NASDAQ:BLUE), Connect Biopharma Hldgs (NASDAQ:CNTB) and Coeptis Therapeutics (NASDAQ:COEP).

What is the forecast, or price target, for Mersana Therapeutics (MRSN) stock?

Mersana Therapeutics has a consensus price target of $6.38.

What is the current price for Mersana Therapeutics (MRSN)?

The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $0.3388 last updated April 22, 2025 at 9:20 AM EDT.

Does Mersana Therapeutics (MRSN) pay a dividend?

There are no upcoming dividends for Mersana Therapeutics.

When is Mersana Therapeutics (NASDAQ:MRSN) reporting earnings?

Mersana Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Mersana Therapeutics (MRSN) going to split?

There is no upcoming split for Mersana Therapeutics.

What sector and industry does Mersana Therapeutics (MRSN) operate in?

Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Mersana Therapeutics Stock Price, Quotes and Forecasts

Mersana Therapeutics (MRSN) Forecast